BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan RY, Chung WH, Chu MT, Chen SJ, Chen HC, Zheng L, Hung SI. Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens. J Immunol Res 2018;2018:4325874. [PMID: 30662919 DOI: 10.1155/2018/4325874] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Kumari S, Mukherjee S, Sinha D, Abdisalaam S, Krishnan S, Asaithamby A. Immunomodulatory Effects of Radiotherapy. Int J Mol Sci 2020;21:E8151. [PMID: 33142765 DOI: 10.3390/ijms21218151] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
2 Li W, Amei A, Bui F, Norouzifar S, Lu L, Wang Z. Impact of Neoantigen Expression and T-Cell Activation on Breast Cancer Survival. Cancers (Basel) 2021;13:2879. [PMID: 34207556 DOI: 10.3390/cancers13122879] [Reference Citation Analysis]
3 Sun H, Hu W, Yan Y, Zhang Z, Chen Y, Yao X, Teng L, Wang X, Chai D, Zheng J, Wang G. Using PAMPs and DAMPs as adjuvants in cancer vaccines. Hum Vaccin Immunother 2021;:1-12. [PMID: 34520322 DOI: 10.1080/21645515.2021.1964316] [Reference Citation Analysis]
4 Singh V, Kesharwani P. Recent advances in microneedles-based drug delivery device in the diagnosis and treatment of cancer. J Control Release 2021;338:394-409. [PMID: 34481019 DOI: 10.1016/j.jconrel.2021.08.054] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pereira ACL, Bezerra KS, Santos JLS, I N Oliveira J, Freire VN, Fulco UL. In silico approach of modified melanoma peptides and their immunotherapeutic potential. Phys Chem Chem Phys 2021;23:2836-45. [PMID: 33470998 DOI: 10.1039/d0cp05322h] [Reference Citation Analysis]
6 George A, Sahin I, Carneiro BA, Dizon DS, Safran HP, El-Deiry WS. Strategies to sensitize cancer cells to immunotherapy. Hum Vaccin Immunother 2021;:1-7. [PMID: 34019474 DOI: 10.1080/21645515.2021.1891817] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Entezari AA, Snook AE, Waldman SA. Guanylyl cyclase 2C (GUCY2C) in gastrointestinal cancers: recent innovations and therapeutic potential. Expert Opin Ther Targets 2021;25:335-46. [PMID: 34056991 DOI: 10.1080/14728222.2021.1937124] [Reference Citation Analysis]
8 Roy S, Sethi TK, Taylor D, Kim YJ, Johnson DB. Breakthrough concepts in immune-oncology: Cancer vaccines at the bedside. J Leukoc Biol. 2020;108:1455-1489. [PMID: 32557857 DOI: 10.1002/jlb.5bt0420-585rr] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 He L, Wang X, Li C, Wan Y, Fang H. Bibliometric analysis of the 100 top-cited articles on immunotherapy of urological cancer. Hum Vaccin Immunother 2022;:1-8. [PMID: 35148255 DOI: 10.1080/21645515.2022.2035552] [Reference Citation Analysis]
10 Li Y, Gao Y, Chu W, Lv J, Li Z, Shi T. Differences in and verification of genetic alterations in chemotherapy and immunotherapy for metastatic melanoma. Aging (Albany NY) 2021;13:23672-88. [PMID: 34675134 DOI: 10.18632/aging.203640] [Reference Citation Analysis]
11 Londhe VY, Date V. Personalized neoantigen vaccines: a glimmer of hope for glioblastoma. Expert Rev Vaccines 2020;19:407-17. [PMID: 32238056 DOI: 10.1080/14760584.2020.1750376] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
12 Deleuze A, Saout J, Dugay F, Peyronnet B, Mathieu R, Verhoest G, Bensalah K, Crouzet L, Laguerre B, Belaud-Rotureau MA, Rioux-Leclercq N, Kammerer-Jacquet SF. Immunotherapy in Renal Cell Carcinoma: The Future Is Now. Int J Mol Sci 2020;21:E2532. [PMID: 32260578 DOI: 10.3390/ijms21072532] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
13 Benvenuto M, Focaccetti C, Izzi V, Masuelli L, Modesti A, Bei R. Tumor antigens heterogeneity and immune response-targeting neoantigens in breast cancer. Semin Cancer Biol 2021;72:65-75. [PMID: 31698088 DOI: 10.1016/j.semcancer.2019.10.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Tian H, Kang Y, Song X, Xu Y, Chen H, Gong X, Zhang W, Xu Y, Xia X, Gao X, Yao W. PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses. Cancer Lett 2020;476:170-82. [PMID: 32092355 DOI: 10.1016/j.canlet.2020.02.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Vaughan HJ, Green JJ. Recent Advances in Gene Therapy for Cancer Theranostics. Curr Opin Biomed Eng 2021;20:100300. [PMID: 34738046 DOI: 10.1016/j.cobme.2021.100300] [Reference Citation Analysis]
16 Chudasama R, Phung Q, Hsu A, Almhanna K. Vaccines in Gastrointestinal Malignancies: From Prevention to Treatment. Vaccines (Basel) 2021;9:647. [PMID: 34199248 DOI: 10.3390/vaccines9060647] [Reference Citation Analysis]
17 Pallerla S, Abdul AURM, Comeau J, Jois S. Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer. Int J Mol Sci 2021;22:E779. [PMID: 33466691 DOI: 10.3390/ijms22020779] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
18 Juanes-Velasco P, Landeira-Viñuela A, Acebes-Fernandez V, Hernández ÁP, Garcia-Vaquero ML, Arias-Hidalgo C, Bareke H, Montalvillo E, Gongora R, Fuentes M. Deciphering Human Leukocyte Antigen Susceptibility Maps From Immunopeptidomics Characterization in Oncology and Infections. Front Cell Infect Microbiol 2021;11:642583. [PMID: 34123866 DOI: 10.3389/fcimb.2021.642583] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Liu H, Pan W, Tang C, Tang Y, Wu H, Yoshimura A, Deng Y, He N, Li S. The methods and advances of adaptive immune receptors repertoire sequencing. Theranostics 2021;11:8945-63. [PMID: 34522220 DOI: 10.7150/thno.61390] [Reference Citation Analysis]
20 Murciano-Goroff YR, Warner AB, Wolchok JD. The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res 2020;30:507-19. [PMID: 32467593 DOI: 10.1038/s41422-020-0337-2] [Cited by in Crossref: 113] [Cited by in F6Publishing: 108] [Article Influence: 56.5] [Reference Citation Analysis]
21 Yu J, Sun H, Cao W, Song Y, Jiang Z. Research progress on dendritic cell vaccines in cancer immunotherapy. Exp Hematol Oncol 2022;11:3. [PMID: 35074008 DOI: 10.1186/s40164-022-00257-2] [Reference Citation Analysis]
22 Makuku R, Seyedmirzaei H, Tantuoyir MM, Rodríguez-Román E, Albahash A, Mohamed K, Moyo E, Ahmed AO, Razi S, Rezaei N. Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article. Int Immunopharmacol 2022;105:108580. [PMID: 35121225 DOI: 10.1016/j.intimp.2022.108580] [Reference Citation Analysis]
23 Hoshino I, Nabeya Y, Takiguchi N, Gunji H, Ishige F, Iwatate Y, Kuwajima A, Shiratori F, Okada R, Shimada H. Inducing multiple antibodies to treat squamous cell esophageal carcinoma. BMC Cancer 2020;20:1007. [PMID: 33069225 DOI: 10.1186/s12885-020-07466-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Christofi T, Baritaki S, Falzone L, Libra M, Zaravinos A. Current Perspectives in Cancer Immunotherapy. Cancers (Basel) 2019;11:E1472. [PMID: 31575023 DOI: 10.3390/cancers11101472] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 21.3] [Reference Citation Analysis]
25 Shindo Y, Hazama S, Tsunedomi R, Suzuki N, Nagano H. Novel Biomarkers for Personalized Cancer Immunotherapy. Cancers (Basel) 2019;11:E1223. [PMID: 31443339 DOI: 10.3390/cancers11091223] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
26 Chen Z, Zhang Q, Zeng L, Zhang J, Liu Z, Zhang M, Zhang X, Xu H, Song H, Tao C. Light-triggered OVA release based on CuS@poly(lactide-co-glycolide acid) nanoparticles for synergistic photothermal-immunotherapy of tumor. Pharmacological Research 2020;158:104902. [DOI: 10.1016/j.phrs.2020.104902] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Jiang T, Shi T, Zhang H, Hu J, Song Y, Wei J, Ren S, Zhou C. Tumor neoantigens: from basic research to clinical applications. J Hematol Oncol 2019;12:93. [PMID: 31492199 DOI: 10.1186/s13045-019-0787-5] [Cited by in Crossref: 88] [Cited by in F6Publishing: 94] [Article Influence: 29.3] [Reference Citation Analysis]
28 Mondlane ER, Abreu-Mendes P, Martins D, Cruz R, Mendes F. The role of immunotherapy in advanced renal cell carcinoma: Review. Int Braz J Urol 2021;47:1228-42. [PMID: 33650838 DOI: 10.1590/S1677-5538.IBJU.2020.0681] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Acebes-Fernández V, Landeria-Viñuela A, Juanes-Velasco P, Hernández AP, Otazo-Perez A, Manzano-Román R, Gongora R, Fuentes M. Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers. Nanomaterials (Basel) 2020;10:E1274. [PMID: 32610601 DOI: 10.3390/nano10071274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
30 Manjili MH. The premise of personalized immunotherapy for cancer dormancy. Oncogene 2020;39:4323-30. [PMID: 32322001 DOI: 10.1038/s41388-020-1295-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
31 Kunimasa K, Goto T. Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges. Int J Mol Sci 2020;21:E597. [PMID: 31963413 DOI: 10.3390/ijms21020597] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
32 Motofei IG. Nobel Prize for immune checkpoint inhibitors, understanding the immunological switching between immunosuppression and autoimmunity. Expert Opin Drug Saf 2021;:1-14. [PMID: 34937484 DOI: 10.1080/14740338.2022.2020243] [Reference Citation Analysis]
33 Chen T, Hu R, Wan Y, Sun F, Wang Z, Yue J, Chen J, Han G, Wei G, Dong Z. Comprehensive mutanome analysis of Lewis lung cancer reveals immunogenic neoantigens for therapeutic vaccines. Biochem Biophys Res Commun 2020;525:607-13. [PMID: 32115148 DOI: 10.1016/j.bbrc.2020.02.132] [Reference Citation Analysis]
34 Shibata H, Zhou L, Xu N, Egloff AM, Uppaluri R. Personalized cancer vaccination in head and neck cancer. Cancer Sci 2021;112:978-88. [PMID: 33368875 DOI: 10.1111/cas.14784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Zhang Z, Lu M, Qin Y, Gao W, Tao L, Su W, Zhong J. Neoantigen: A New Breakthrough in Tumor Immunotherapy. Front Immunol 2021;12:672356. [PMID: 33936118 DOI: 10.3389/fimmu.2021.672356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Erfanian N, Derakhshani A, Nasseri S, Fereidouni M, Baradaran B, Jalili Tabrizi N, Brunetti O, Bernardini R, Silvestris N, Safarpour H. Immunotherapy of cancer in single-cell RNA sequencing era: A precision medicine perspective. Biomed Pharmacother 2021;146:112558. [PMID: 34953396 DOI: 10.1016/j.biopha.2021.112558] [Reference Citation Analysis]
37 Kumbhari A, Egelston CA, Lee PP, Kim PS. Mature Dendritic Cells May Promote High-Avidity Tuning of Vaccine T Cell Responses. Front Immunol 2020;11:584680. [PMID: 33193401 DOI: 10.3389/fimmu.2020.584680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Babich M, Sharma A, Li T, Radosevich JA. Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e08988] [Reference Citation Analysis]
39 Francian A, Widmer A, Olsson T, Ramirez M, Heald D, Rasic K, Adams L, Martinson H, Kullberg M. Delivery of toll-like receptor agonists by complement C3-targeted liposomes activates immune cells and reduces tumour growth. J Drug Target 2021;29:754-60. [PMID: 33472457 DOI: 10.1080/1061186X.2021.1878364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Wang N, Wang R, Zhang X, Li X, Liang Y, Ding Z. Spatially-resolved proteomics and transcriptomics: An emerging digital spatial profiling approach for tumor microenvironment. Vis Cancer Med 2021;2:1. [DOI: 10.1051/vcm/2020002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]